We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0RGI market cap is 2.23B. The company's latest EPS is EUR 0.9819 and P/E is 75.06.
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 64.67M | 63.25M | 66.8M | 65.89M | 103.99M |
Operating Income | -22.07M | -17.37M | 1.96M | 28.3M | 28.06M |
Net Income | -18.11M | -24.42M | -7.9M | 21.67M | 17.23M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 625.69M | 585.16M | 596.16M | 805.56M | 759.59M |
Total Liabilities | 180.83M | 191.43M | 196.04M | 292.88M | 295.8M |
Total Equity | 444.85M | 393.73M | 400.13M | 512.68M | 463.79M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -10.16M | -18.85M | 12.99M | 12.61M | 33.23M |
Investing | -71.78M | -48.69M | 75.45M | 24.86M | 1.69M |
Financing | 144.39M | -34.46M | -11.88M | -27.25M | -46.13M |
Market Cap | 2.23B |
Price to Earnings Ratio | 75.06 |
Price to Sales Ratio | 12.43 |
Price to Cash Ratio | 6.96 |
Price to Book Ratio | 2.79 |
Dividend Yield | - |
Shares Outstanding | 17.54M |
Average Volume (1 week) | 3.17k |
Average Volume (1 Month) | 1.63k |
52 Week Change | 0.00% |
52 Week High | 126.90 |
52 Week Low | 126.90 |
Spread (Intraday) | 0 (0%) |
Company Name | Cosmo Pharmaceuticals Nv |
Address |
riverside ii dublin 20020 |
Website | https://www.cosmopharmaceuticals.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions